Inhibition of one of these NADPH-generating enzymes, glucose-6-phosphate dehydrogenase, has been demonstrated in breast cancer in both 2D cellular models as well as a nude mouse model (Mele et al. 2018) to have an excellent inhibitory proliferative effect. Here, DECR1 is linked to breast cancer.